Post Content
Artisan Partners, an investment management company, released its “Artisan Value Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The equity market rally persisted in the third quarter as investors ignored tariffs, buoyed by strong corporate earnings, rising AI investment, and prospects of economic support from US fiscal policy and lower interest rates. Against this backdrop, the fund’s Investor Class ARTLX, Advisor Class APDLX, and Institutional Class APHLX returned 0.83%, 0.91%, and 0.90%, respectively, in the third quarter compared to a 5.33% return for the Russell 1000 Value Index. In addition, you can check the top 5 holdings of the fund to know its best picks in 2025.
In its third-quarter 2025 investor letter, Artisan Value Fund highlighted stocks such as The Cigna Group (NYSE:CI). The Cigna Group (NYSE:CI) is a US-based insurance company that offers insurance and related products and services. The one-month return of The Cigna Group (NYSE:CI) was 0.70%, and its shares lost 0.05% of their value over the last 52 weeks. On December 29, 2025, The Cigna Group (NYSE:CI) stock closed at $276.01 per share, with a market capitalization of $73.73 billion.
Artisan Value Fund stated the following regarding The Cigna Group (NYSE:CI) in its third quarter 2025 investor letter:
“We swapped one managed care company for another in purchasing Elevance and selling The Cigna Group (NYSE:CI). Both companies operate health insurance businesses and trade cheaply, but their business mixes are different. Formerly known as Anthem and Wellpoint, Elevance is one of the nation’s largest health insurers and the largest for-profit entity in the Blue Cross Blue Shield Association. The company operates in commercial, Medicare Advantage and Medicaid through its health benefits segment and provides pharmacy benefits, life insurance and disability insurance. Cigna has a much larger pharmacy benefits management (PBM)business that generates over 50% of operating profits. There are rumblings in Washington about PBM reform, which should pose a greater risk to Cigna than to Elevance.”
The Cigna Group (NYSE:CI) is not on our list of 30 Most Popular Stocks Among Hedge Funds. According to our database, 78 hedge fund portfolios held The Cigna Group (NYSE:CI) at the end of the third quarter, compared to 80 in the previous quarter. While we acknowledge the potential of The Cigna Group (NYSE:CI) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
Terms and Privacy Policy